Articles

A rigorous emphasis on primary and specialty care, research, and education sets Penn State Health Milton S. Hershey Medical Center apart in regional healthcare delivery.
As a healthcare administrator for more than 30 years, I have seen dramatic transformations in health care, but the greatest change has been in cardiovascular surgery. Thirty years ago, I would not have believed that most heart surgeries would someday be performed with tiny incisions in the side of the chest or groin. One of the greatest rewards of working at PinnacleHealth has been witnessing firsthand how these advances have helped patients right here in Central Pennsylvania.
At Penn State Health Milton S. Hershey Medical Center, physician-scientists provide advanced treatments for acute and chronic heart conditions, while furthering the Heart and Vascular Institute’s mission to develop and perfect lifesaving therapies and technologies.
As technologies and techniques have advanced in recent years, Gamma Knife radiosurgery has become a vital tool for enhancing outcomes among patients with brain tumors and other complex neurological disorders. Penn State Health Milton S. Hershey Medical Center recently reaffirmed its long-standing commitment to provide the most advanced care in the region by upgrading to the latest iteration of the Gamma Knife radiosurgery system: Leksell Gamma Knife® Icon™.
ESTABLISHED IN 2000, Penn State Cancer Institute, recognized as an American College of Surgeons Commission on Cancer-accredited facility, has evolved into a premier academic oncology center that encompasses clinical care, research, education and outreach. Since 2009, the 178,000-square-foot facility on the Milton S. Hershey Medical Center campus has served as the hub for nearly 160 clinicians, researchers and faculty members based in Hershey and University Park, State College in Centre County. The Cancer Institute care teams see nearly 2,000 individual cases annually.
At Penn State Children’s Hospital, the use of 3-D printing to create models of complex heart anatomy provides an effective tool for enhancing surgical outcomes.
With a commitment to continually upgrading its capabilities to provide optimal patient care, Penn State Health Milton S. Hershey Medical Center has become a pioneer in the use of robotic technology for surgical procedures of the head and neck.
In May of 2013, PinnacleHealth embarked on an exciting journey in caring for patients with blocked heart arteries when it began participating in a three-year clinical trial for the first-of-its-kind drug-eluting Absorb Bioresorbable Vascular Scaffold (BVS).
When Lancaster General Health (LG Health) became part of the University of Pennsylvania Health System (Penn Medicine) in August 2015, the organizations formalized a well-established, productive partnership — while setting ambitious goals of providing even greater patient access to leading-edge care. A little over a year later, their collaboration has yielded significant progress in patient care, medical-record sharing and clinical research, with further advances anticipated.
Cooperation, innovation and a passion for saving young lives are the driving forces behind the Pediatric Oncology Experimental Therapeutics Program at Penn State Children’s Hospital.
Clinicians at Hershey Medical Center have taken cranial radiosurgery to the next level with Leksell Gamma Knife® IconTM, the latest advance in Elekta’s Gamma Knife system.
Frustrated with insurance-based care, increasing numbers of physicians are turning to direct primary care to provide patients across the socioeconomic spectrum simpler, more personalized treatment.
Childhood cancer survivors living with chronic conditions as adults may experience a kind of accelerated aging due to the late effects of cancer treatment. However, survivors with no chronic conditions enjoy a quality of life similar to that of individuals with no history of cancer, according to a recent study.
Circadian rhythm disorders, such as irregular sleep-wake rhythms, are hallmarks of Parkinson’s disease. The medical community has traditionally believed the disorders are a side effect of Parkinson’s, but a recently published study is challenging that view.
As the healthcare industry changes and more Americans become insured, the clinical roles of nurse practitioners (NPs) and physician assistants (PAs) have grown. While that growth is clearly a response to greater need, opinions about the shifting care paradigm are not universally shared.
The EHR adoption rate among physicians in the United States is high — greater than 80 percent, according to federal government data — but with federal meaningful use (MU) incentives drying up, what will it take to get the holdouts on board?
Melanoma patients frequently lack the knowledge or confidence to perform regular, effective skin self-exams (SSEs), according to recent research.
Studies point to a frequent disconnect between the priorities of clinical investigators and patient and physician end users. Engaging patients and other stakeholders in research prioritization can enhance study relevance and may even shorten the time it takes to bring scientific discoveries from the laboratory to the bedside.
A newer class of medications that enables the immune system to identify and attack diseased cells is transforming the way clinicians fight advanced melanoma. At the head of that charge is the drug pembrolizumab.
The synergies created by the joining of Lancaster General Health and the University of Pennsylvania Health System (Penn Medicine) enable providers throughout the system to work in an environment of close collaboration that benefits patients and physicians alike.